Case Report

The Journal of the Korean Rheumatism Association 2007; 14(4): 384-389

Published online December 30, 2007

© Korean College of Rheumatology

Cyclosporine으로 치료된 전신홍반루푸스에 의한 재생불량빈혈 1예

이승근ㆍ김지량ㆍ이봉은ㆍ설희윤ㆍ백승훈ㆍ조미라ㆍ이정욱ㆍ김성일ㆍ이준희

부산대학교 의학전문대학원 내과학교실

A Case of Aplastic Anemia Associated with Systemic Lupus Erythematosus: Successful Treatement with Cyclosporine

Seong Geun Lee, M.D., Ji Ryang Kim, M.D., Bong Eun Lee, M.D., Hee Yun Seol, M.D., Seung Hoon Baek, M.D., Mi Ra Cho, M.D., Jeong Wook Lee, M.D., Sung Il Kim, M.D., Jun Hee Lee, M.D.

Department of Internal Medicine, School of Medicine, Pusan National University, Busan, Korea

Correspondence to : Jun Hee Lee

Abstract

Systemic lupus erythematosus(SLE) is autoimmune disease in which involves systemic organs. Hematological manifestations are common in patients with SLE but aplastic anemia is very rare and, although various immunosuppressants have been tried, there is no established treatment in aplastic anemia associated with SLE. Furthermore, disease course and prognosis may be different from other aplastic anemia. A 42-year-old woman presented with fever, chilling, myalgia, general weakness, pancytopenia. Her bone marrow aspirate and biopsy revealed almost acellular bone marrow with rare foci of hematopoietic elements and she was diagnosed with SLE simultaneously. High-dose methyprednisolone, prednisolone and cyclophosphamide therapies had been unsuccessful in controlling pancytopenia. Cyclosproine was started and the aplastic anemia was responded. Now she was free of transfusion with more than 10 g/dL of hemoglobin.

Keywords Systemic lupus erythematosus, Aplastic anemia, Cyclosporine

Article

Case Report

The Journal of the Korean Rheumatism Association 2007; 14(4): 384-389

Published online December 30, 2007

Copyright © Korean College of Rheumatology.

Cyclosporine으로 치료된 전신홍반루푸스에 의한 재생불량빈혈 1예

이승근ㆍ김지량ㆍ이봉은ㆍ설희윤ㆍ백승훈ㆍ조미라ㆍ이정욱ㆍ김성일ㆍ이준희

부산대학교 의학전문대학원 내과학교실

A Case of Aplastic Anemia Associated with Systemic Lupus Erythematosus: Successful Treatement with Cyclosporine

Seong Geun Lee, M.D., Ji Ryang Kim, M.D., Bong Eun Lee, M.D., Hee Yun Seol, M.D., Seung Hoon Baek, M.D., Mi Ra Cho, M.D., Jeong Wook Lee, M.D., Sung Il Kim, M.D., Jun Hee Lee, M.D.

Department of Internal Medicine, School of Medicine, Pusan National University, Busan, Korea

Correspondence to:Jun Hee Lee

Abstract

Systemic lupus erythematosus(SLE) is autoimmune disease in which involves systemic organs. Hematological manifestations are common in patients with SLE but aplastic anemia is very rare and, although various immunosuppressants have been tried, there is no established treatment in aplastic anemia associated with SLE. Furthermore, disease course and prognosis may be different from other aplastic anemia. A 42-year-old woman presented with fever, chilling, myalgia, general weakness, pancytopenia. Her bone marrow aspirate and biopsy revealed almost acellular bone marrow with rare foci of hematopoietic elements and she was diagnosed with SLE simultaneously. High-dose methyprednisolone, prednisolone and cyclophosphamide therapies had been unsuccessful in controlling pancytopenia. Cyclosproine was started and the aplastic anemia was responded. Now she was free of transfusion with more than 10 g/dL of hemoglobin.

Keywords: Systemic lupus erythematosus, Aplastic anemia, Cyclosporine

JRD
Jan 01, 2025 Vol.32 No.1, pp. 1~7
COVER PICTURE
Cumulative growth of rheumatology members and specialists (1980~2024). Cumulative distribution of the number of the (A) Korean College of Rheumatology members and (B) rheumatology specialists. (J Rheum Dis 2025;32:63-65)

Stats or Metrics

Share this article on

  • line

Related articles in JRD

Journal of Rheumatic Diseases

pISSN 2093-940X
eISSN 2233-4718
qr-code Download